Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2009
09/02/2009CN101519421A Method for preparing high-purity demethylzelasteral
09/02/2009CN101519402A Thiochromone compound, synthetic method and application thereof in preparing antifungal medicaments
09/02/2009CN101519375A Antifungal pyrazoline-substituting compound and preparation method and application thereof
09/02/2009CN101519368A Small molecule entry inhibitors
09/02/2009CN101519361A Preparation process of lavo-ofloxacin and ofloxacin
09/02/2009CN101518649A Compound preparation for treating ophthalmic infection and inflammation
09/02/2009CN101518648A Soluble receptor BR43x2 and methods of using
09/02/2009CN101518647A Human papilloma virus preventative vaccine, construction method and application
09/02/2009CN101518644A Application of Ang-2 and genes thereof in pharmacy
09/02/2009CN101518628A Medicament for treating AIDS and preparation method
09/02/2009CN101518610A Orthopedic persistent ailment treating medicament and preparation method thereof
09/02/2009CN101518608A Anti-candidiasis albrican cream and preparation method thereof
09/02/2009CN101518602A Anti-herpes zoster traditional Chinese medical composition and preparation method thereof
09/02/2009CN101518600A Chinese medicinal composition for treating bacterial or fungal dermatosis and preparation method thereof
09/02/2009CN101518598A Tea oral tablet and preparation method thereof
09/02/2009CN101518592A Granule used for treating cold due to wind-heat and preparation method thereof
09/02/2009CN101518585A Holding prescription for treating influenza
09/02/2009CN101518578A Powder for curing dermatophytosis and preparation method thereof
09/02/2009CN101518574A Anti-human papilloma virus (anti-HPV) external effervescent tablet and preparation method and application thereof
09/02/2009CN101518569A Human sterilizing liquid containing majoram oil and production method thereof
09/02/2009CN101518549A Research and application of Mycobacterium extract
09/02/2009CN101518545A Synthesis and surface decorating method of rare-earth nanometer compound material
09/02/2009CN101518544A Quickly-effective beriberi powder
09/02/2009CN101518543A Preparation method and product of lincomycin-gentamicin compound injection
09/02/2009CN101518530A Stable solid composite medicament of compound penicillin
09/02/2009CN101518526A Drug combination
09/02/2009CN101518522A Allicin external preparation and prepration method thereof
09/02/2009CN101518514A Econazole nitrate microemulsion aerosol and method for preparing same
09/02/2009CN101518471A Antibiotic artificial hip joint
09/02/2009CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof
09/02/2009CN100534529C Ordered molecular presentation of antigens, method of preparation and use
09/02/2009CN100534506C Chinese medicinal mixture for treating viral hepatitis
09/01/2009US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling
09/01/2009US7582730 an iron-regulated protein found in Neisseria gonorrhoeae or Neisseria meningitidis outer membranes; immunizing a host against gonococcal and meningococcal diseases, such as gonorrhea, meningitis
09/01/2009US7582675 Flavonoid compound and process for producing the same
09/01/2009US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics
09/01/2009US7582659 effective against aerobic and anerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci; 1-[5(R)-3-[4-[2-[(1 alpha ,5 alpha ,6 beta )-6-Cyano-3-azabicyclo[3.1.0]hexan-6-yl]pyridin-5-yl]-3-fluorophenyl]-2-oxooxazolidin-5-ylmethyl]-1,2,3-triazole; side effect reduction
09/01/2009US7582657 Vanilloid receptor ligands and their use in treatments
09/01/2009US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
09/01/2009US7582642 4-{9-Isopropyl-6-[(pyridin-3-ylmethyl)-amino]-9H-purin-2-ylamino}-2-methyl-hexan-3-ol;antiproliferative agents; viricides; alopecia; strokes; central nervous system diorders; neurodegenerative diseases; antidiabetic agents; mitosis; cyclin dependent kinase inhibitors; protein kinase inhibitors
09/01/2009US7582641 Gyrase inhibitors and uses thereof
09/01/2009US7582627 3-aminoquinazolin-2,4-dione antibacterial agents
09/01/2009US7582624 Benzodiazepine derivatives and pharmaceutical compositions containing them
09/01/2009US7582614 Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection
09/01/2009US7582613 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
09/01/2009US7582604 Template-fixed peptidomimetics with antibacterial activity
09/01/2009US7582603 Treatment of gastrointestinal inflammation by administering a peptide antagonist of tight junction opening that binds to the zonula occludens receptor, yet does not physiologically modulate the opening of mammalian tight junctions; celiac disease, inflammatory bowel disease
09/01/2009US7582437 Adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof
09/01/2009US7582301 Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides
09/01/2009US7582288 Methods of targeting multiple cytokines
09/01/2009US7582287 Method for treating cervical cancer
09/01/2009CA2467378C Cereal beta glucan compositions, methods of preparation and uses thereof
09/01/2009CA2431206C Combination drugs containing anti-sepsis cycloalkene compound
09/01/2009CA2420640C Combination preparations of 3-n-formyl hydroxy amino propyl phosphonic acid derivatives or 3-n-acetyl hydroxy amino propyl phosphonic acid derivatives together with special pharmaceutical active ingredients
09/01/2009CA2400804C Stable emulsion compositions of cycloalkene derivatives
09/01/2009CA2385867C Sustained release form comprising alpha-lipoic acid or derivatives thereof
09/01/2009CA2272540C Anti-oxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same
09/01/2009CA2210812C T-cell affecting peptides
09/01/2009CA2158651C Multicomponent clostridial vaccines using saponin adjuvants
08/2009
08/27/2009WO2009105729A2 Immunogenic influenza composition
08/27/2009WO2009105328A2 Inorganic sorbent copolymer
08/27/2009WO2009105258A1 Oligomer conjugates of heteropentacyclic nucleosides
08/27/2009WO2009105192A2 Use of saccharides cross-reactive with bacillus anthracis spore glycoprotein as a vaccine against anthrax
08/27/2009WO2009105152A2 Virus-like particles as vaccines for paramyxovirus
08/27/2009WO2009104831A1 Use of mutant hiv-1 protease or siv protease as an adjuvant
08/27/2009WO2009104761A1 Anti-viral agents, anti-viral fibers and anti-viral fiber structures
08/27/2009WO2009104670A1 Antimicrobial and antiviral agent and method for use thereof
08/27/2009WO2009104159A1 Oxazolidinone derivatives
08/27/2009WO2009104045A1 Ophthalmic gemifloxacin compositions for the treatment of ocular infections
08/27/2009WO2009103821A2 Means for treating virus infections
08/27/2009WO2009103493A1 Sgk1 as a therapeutic and diagnostic target for viral diseases
08/27/2009WO2009103319A2 Proteins ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis vulgaris and poststreptococcal diseases
08/27/2009WO2009103312A1 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases
08/27/2009WO2009103243A1 CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS POLYMERASE PAc-PB1n COMPLEX AND USES THEREOF
08/27/2009WO2009103209A1 Stable s-(-)- nadifloxacin-l-arginine composition, its preparation method and use
08/27/2009WO2009103199A1 A g-csf conjugate modified by water-soluble polymer
08/27/2009WO2009083663A3 Cyclic peptides comprising at least one aza-β3-aminoacyl residue and uses thereof
08/27/2009WO2009076778A8 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
08/27/2009WO2009076200A3 Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1h-benzo[d]imidazol-2-yl)urea
08/27/2009WO2009071860A3 G immunoglobulin used against anthrax toxins
08/27/2009WO2009070564A3 Compositions and methods for prevention of infection in transcutaneous osseointegrated implants
08/27/2009WO2009033811A3 Therapeutic uses of muroctasin and kisspeptin13 and compositions thereof
08/27/2009WO2009033760A3 Use of fibronectin fragment (196-203 ) as a therapeutic agent
08/27/2009WO2009033668A3 Use of a peptide as a therapeutic agent
08/27/2009WO2009033667A3 Use of a peptide as a therapeutic agent
08/27/2009WO2008142513A3 Phosphate-modified oligonucleotide analogs with immunostimulatory activity
08/27/2009WO2008095093A3 Method of increasing cellular function and health of glutathione deficient animals
08/27/2009WO2007143231A3 Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
08/27/2009US20090217392 Anti- integrin antibodies, compositions, methods and uses
08/27/2009US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells
08/27/2009US20090215982 Glycopeptide derivatives and pharmaceutical compositions containing the same
08/27/2009US20090215869 Hepatitis c virus non-structural ns3/4a fusion gene
08/27/2009US20090215854 Antimicrobial compositions, products and methods employing same
08/27/2009US20090215819 Anti-infective and immunomodulatory compounds
08/27/2009US20090215789 Cyclic hexadepsipeptides, processes for their production and their use as pharmaceuticals
08/27/2009US20090215779 Oxadiazole derivatives as dgat inhibitors
08/27/2009US20090215778 Alpha-substituted Arylmethyl Piperazine Pyrazolo [1,5-alpha]Pyrimidine Amide Derivatives
08/27/2009US20090215762 Siloxane polymer containing tethered levofloxacin
08/27/2009US20090215747 Heterocyclic compounds as inhibitors of beta-lactamases
08/27/2009US20090215739 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles